 NEW YORK and CHICAGO, July 28, 2021 PRNewswire -- Wolf Haldenstein Adler Freeman Herz LLP announces that a federal securities class action lawsuit has been filed against Orphazyme AS NASDAQ: ORPH Orphazyme in the United States District Court for the Northern District of Illinois on behalf of those who purchased or otherwise acquired the American Depositary Receipts ADRs of Orphazyme AS between September 29, 2020 and June 18, 2021, inclusive the Class Period. All investors who purchased the ADRs of Orphazyme AS and incurred losses are urged to contact the firm immediately at or 800 575-0735 or 212 545-4774. 